MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Wed, Feb 22, 2023
Feb 22
exercised or converted securities in ALKS
12,038 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +13.40% (+6,693 shares)
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.76%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback